Compagnie Lombard Odier SCmA’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 479 |
|
|
2024
Q1 | – | Sell |
-14,000
| Closed | -$70.3K | – | 556 |
|
|
2023
Q4 | $70.3K | Hold |
14,000
| – | – | ﹤0.01% | 384 |
|
|
2023
Q3 | $23.7K | Hold |
14,000
| – | – | ﹤0.01% | 476 |
|
|
2023
Q2 | $38.9K | Hold |
14,000
| – | – | ﹤0.01% | 432 |
|
|
2023
Q1 | $25.5K | Hold |
14,000
| – | – | ﹤0.01% | 504 |
|
|
2022
Q4 | $71K | Hold |
14,000
| – | – | ﹤0.01% | 434 |
|
|
2022
Q3 | $70K | Hold |
14,000
| – | – | ﹤0.01% | 429 |
|
|
2022
Q2 | $52K | Hold |
14,000
| – | – | ﹤0.01% | 430 |
|
|
2022
Q1 | $79K | Buy |
+14,000
| New | +$79K | ﹤0.01% | 400 |
|